Article Archive

Date
Article  

21-DEC-07

AVI BioPharma Announces Commencement of Dosing in Clinical Trial for Duchenne Muscular Dystrophy

12-DEC-07

Stem Cells Ease Disease Symptoms in Mice

01-NOV-07

19-0CT-07 Clinical trial offers hope for young men with muscular dystrophy
19-0CT-07 Muscular Dystrophy Trial to Start
16-0CT-07 PTC Therapeutics Announces Results From Phase II Study of PTC124

 02-OCT-07

A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.
26-SEP-07
26-SEP-07
(2007 Annual Meeting of  The American Society of Human Genetics) Antisense-mediated exon 51 skipping restores local dystrophin expression in muscle of Duchenne muscular dystrophy patients.
17-SEP-07
"Patch" Bid to Treat Muscle Disease
17-SEP-07
08-AUG-07 Santhera, Takeda Extend Pact for Idebenone in DMD
08-AUG-07 AVI BioPharma Announces Refocused Clinical Development Strategy
10-JUL-07 PTC Therapeutics Announces $15.4 Million NIH Research Grant for Duchenne Muscular Dystrophy
02-MAY-07 Dr. Giulio Cossu to Validate Adult Stem Cell Study Under GMP Conditions
02-MAY-07 Interview with Dr. Giulio Cossu
17-APR-07
17-APR-07
Letter from Dr. Guenter  Scheuerbrandt Research for a Duchenne Therapy: Questions and Answers
27-MAR-07
25-MAR-07
DEC-06
NOV-06
26-AUG-06
Prosensa's First Intramuscular Human Trial Successful

 

Powered by CityMax.com